Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left atrial structural and functional remodeling following balloon mitral valvuloplasty.

The international journal of cardiovascular imaging·2020
Same author

Impact of balloon mitral valvuloplasty on left ventricular rotational deformation: Magnetic Resonance Imaging follow up study.

The international journal of cardiovascular imaging·2020
Same author

Long-term results up to 19 years of mitral balloon valvuloplasty.

Asian cardiovascular & thoracic annals·2009
Same author

Long-term (up to 18 years) clinical and echocardiographic results of mitral balloon valvuloplasty in 531 consecutive patients and predictors of outcome.

Cardiology·2009
Same author

Twenty-two years of follow-up results of balloon angioplasty for discreet native coarctation of the aorta in adolescents and adults.

American heart journal·2008
Same author

Immediate and long-term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension.

The Journal of heart valve disease·2008
Same journal

Intermittent Fasting in Chronic Heart Failure: A Systematic Review of Safety and Physiological Outcomes.

Journal of the Saudi Heart Association·2026
Same journal

Right Ventricular-Pulmonary Artery Coupling Predicts Early Myocardial Strain Improvement in SGLT2 Inhibitor-Treated HFrEF.

Journal of the Saudi Heart Association·2026
Same journal

Comments on the Letter "Bridging the Gap: The Critical Next Steps for Implementing Genetic Risk Scores in Myocardial Infarction Prevention in Saudi Arabia".

Journal of the Saudi Heart Association·2026
Same journal

Bridging the Gap: The Critical Next Steps for Implementing Genetic Risk Scores in Myocardial Infarction Prevention in Saudi Arabia.

Journal of the Saudi Heart Association·2026
Same journal

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities, and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Journal of the Saudi Heart Association·2026
Same journal

Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease.

Journal of the Saudi Heart Association·2026
See all related articles

Related Experiment Video

Updated: May 8, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Mitral balloon valvuloplasty.

Mohamed Eid Fawzy1

  • 1October 6 University Medical School, Cairo, Egypt.

Journal of the Saudi Heart Association
|August 21, 2013
PubMed
Summary
This summary is machine-generated.

Percutaneous mitral balloon valvuloplasty (MBV) is a safe and effective treatment for severe mitral stenosis, offering comparable results to surgery with lower complication rates. Patient selection and favorable valve morphology significantly improve long-term outcomes and reduce restenosis.

Keywords:
Mitral balloon valvuloplasty

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Related Experiment Videos

Last Updated: May 8, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous mitral balloon valvuloplasty (MBV) was developed in 1984 as an alternative to surgical commissurotomy for mitral stenosis.
  • MBV has become the preferred treatment for severe, pliable rheumatic mitral stenosis due to improved patient selection and procedural experience.

Purpose of the Study:

  • To review the efficacy and safety of MBV for severe mitral stenosis.
  • To analyze complication rates, restenosis rates, and long-term outcomes associated with MBV.
  • To discuss the impact of MBV on associated cardiac conditions and its application in specific patient populations.

Main Methods:

  • Review of reported complications, including mortality, cerebral accidents, and mitral regurgitation requiring surgery.
  • Analysis of randomized trials comparing MBV with surgical commissurotomy for hemodynamic results.
  • Evaluation of restenosis rates based on patient selection, valve morphology, and follow-up duration.

Main Results:

  • MBV exhibits low complication rates: mortality (0-0.5%), cerebral accident (1-2%), and mitral regurgitation requiring surgery (1.6-3%), comparing favorably to surgical outcomes.
  • Restenosis rates vary (4-70%), influenced by patient selection and valve morphology. Long-term restenosis-free survival is significantly better in patients with favorable mitral morphology (e.g., MES ≤ 8).
  • MBV demonstrates favorable long-term event-free survival, particularly for patients with favorable mitral morphology.

Conclusions:

  • MBV is a safe and effective treatment for severe mitral stenosis, with complication rates lower than surgical commissurotomy.
  • Favorable mitral valve morphology is a key predictor of better long-term outcomes and reduced restenosis after MBV.
  • The review addresses MBV's effects on pulmonary hypertension, tricuspid regurgitation, ventricular function, and its use in special circumstances like pregnancy and pediatric cases.